A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain

Tanja Opriessnig, Priscilla Freitas Gerber, Chao-Ting Xiao, Mark Mogler, Patrick G Halbur

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain'. Together they form a unique fingerprint.

Veterinary Science and Veterinary Medicine

Immunology and Microbiology